WO2000074573A1 - Pelvic displacement prosthesis for radioprotection of the small bowel - Google Patents

Pelvic displacement prosthesis for radioprotection of the small bowel Download PDF

Info

Publication number
WO2000074573A1
WO2000074573A1 PCT/US1999/012220 US9912220W WO0074573A1 WO 2000074573 A1 WO2000074573 A1 WO 2000074573A1 US 9912220 W US9912220 W US 9912220W WO 0074573 A1 WO0074573 A1 WO 0074573A1
Authority
WO
WIPO (PCT)
Prior art keywords
prosthesis
affixed
pelvis
pelvic
pelvic displacement
Prior art date
Application number
PCT/US1999/012220
Other languages
French (fr)
Inventor
Frederick L. Coe
Alexander F. Burnett
Charles P. Morrow
Original Assignee
Bioenterics Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioenterics Corporation filed Critical Bioenterics Corporation
Priority to PCT/US1999/012220 priority Critical patent/WO2000074573A1/en
Priority to AU43275/99A priority patent/AU4327599A/en
Publication of WO2000074573A1 publication Critical patent/WO2000074573A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/04Protection of tissue around surgical sites against effects of non-mechanical surgery, e.g. laser surgery
    • A61B2090/0409Specification of type of protection measures
    • A61B2090/0436Shielding
    • A61B2090/0454Shielding by reflection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00Radiation therapy
    • A61N5/10X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092Details
    • A61N2005/1094Shielding, protecting against radiation

Definitions

  • the present invention relates to a pelvic displacement prosthesis for radioprotection of the small intestines (bowel), and a method therefor, in which the prosthesis is inserted into the pelvis to elevate the small bowel out of the pelvic cavity during radiation therapy.
  • Radiation can be an effective therapy in early stage cervical carcinoma and is the treatment of choice in later stage disease.
  • the patient receives between 4500 and 5040 centiGray (rads) of radiation via external beam teletherapy to the whole pelvis followed with brachytherapy implants which are placed directly on the tumor.
  • the purpose of the whole pelvic radiation is to sterilize microscopic disease which may be in the lymph nodes, as well as to shrink the size of the primary tumor.
  • the dosage to the whole pelvis is calculated to be within small bowel tolerance to radiation.
  • the other primary structures in the pelvis, the bladder and colon, have a greater tolerance to radiation. If the radiation dosage to the pelvis could be raised without increasing the rate of radiation-related bowel complications, then the curative potential of the radiation would be enhanced.
  • a prosthetic bladder which is connected via tubing to a subcutaneous port so that the device can be insufflated or desufflated as needed during radiation therapy to elevate the small intestines out of the pelvic cavity.
  • the device was used on 11 patients with none developing a complication in the follow-up period. The usual tolerable dose of radiation to the pelvis was increased in several patients secondary to the protection of the small intestine. This device was placed through a laparotomy and required a second small laparotomy to remove the instrument.
  • an infusion port was placed beneath the skin of the abdomen to access the prosthetic bladder. This requires a separate incision to remove. While the inflated device did produce discomfort related to bowel and bladder pressure in some patients, inflation need occur only during the time the patient is receiving radiation, then the prosthetic bladder can be deflated for the remainder of the day.
  • the prosthesis of the present invention integrates an expandable shell of sufficient shape and volume to elevate the small intestine out of the pelvic area during radiation when insufflated or filled.
  • the prosthesis is connected via tubing to a valve or infusion port and can be filled with saline or other biologically compatible fluids.
  • the tubing is located on the anterior or distal end of the device, so that, when the prosthesis is in place, the tubing will be located next to the anterior abdominal wall and away from the small intestine.
  • the prosthesis of the present invention is designed so that, in its unfilled state, the prosthesis is of a size and shape that it can be placed and removed without a major surgical procedure.
  • the device may be removed by pulling on the tubing to bring the prosthesis up through the fascia such that any shearing forces are away from the small intestine thereby minimizing the risk of tearing the bowel.
  • the invention provides for a novel pelvic displacement prosthesis for radioprotection of the small bowel.
  • the pelvic displacement prosthesis includes a hollow frustum- shaped shell.
  • the pelvic displacement prosthesis includes a hollow shell and one or more manipulation loops affixed to the exterior thereof.
  • the pelvic displacement prosthesis includes a hollow frustum-shaped shell and one or more manipulation loops affixed to the exterior thereof .
  • the pelvic displacement prosthesis is inserted into the pelvis of a patient via an incision, laparotomy or laparoscopy.
  • One or more manipulation loops are used to position the prosthesis within the pelvis. Fluid is supplied to or removed from the prosthesis through a tube connected to a valve or infusion port to insufflate or desufflate the shell. During treatment, radiation is applied to the desired area of the pelvis. Following treatment, the empty prosthesis is removed through an incision, laparotomy or laparoscopy using the tube or one or more of the manipulation loops.
  • FIG. 1 is an elevation view of a pelvic displacement prosthesis embodying aspects of the invention.
  • Fig. 2 is a plan view of a pelvic displacement prosthesis embodying aspects of the invention.
  • This embodiment of the pelvic displacement prosthesis is expandable with a capacity on the order of 750 - 1500 cc without approaching its restrictive compliance (i.e. without approaching a shell's bursting point).
  • the shape of the prosthesis is such that upon insufflation it will conform to the pelvic anatomy, such as a circular or other shaped frustum.
  • the prosthesis may be made with one or more manipulation loops which can be sewn to the peritoneum at approximately the pelvic brim and at the base of the exenteration (tumor) site.
  • This embodiment of the prosthesis is made of material safe for long-term (2-3 months) intraperitoneal placement, such as silicone elastomer.
  • This embodiment of the prosthesis is minimally radio-opaque so that the pelvis can be evaluated by standard radiologic procedures if a problem were to develop while on therapy.
  • This embodiment of the prosthesis is fluidly connected to an infusion port via silicone tubing approximately 24 inches long so that it can be safely routed to an exit site out of the radiation field.
  • Fig. 1 is an elevation view
  • Fig. 2 is a plan view, of a pelvic displacement prosthesis 100 embodying aspects of the present invention.
  • the pelvic displacement prosthesis 100 includes shell 1, valve patch 2, manipulation loops 3a, 3b and tubing 6.
  • Shell 1 has a hollow frustum, or truncated-cone, shape having an axis 8.
  • the radius of the proximal end of shell is smaller than that of its distal end.
  • the proximal and distal ends of shell 1 have outwardly-projecting shallow conical surfaces.
  • the extreme distal end of shell 1 is reinforced by reinforcement sheet 5.
  • Valve patch 2 is affixed via a fluid-tight connection to the distal end of shell 1.
  • the axis of valve patch 2 is located at a radial distance A from the outer diameter of the distal end of shell 1.
  • the connection between shell 1 and valve patch 2 is reinforced by reinforcement sheet 7.
  • Tubing 6 is affixed via a fluid-tight connection to valve patch 2.
  • Manipulation loop 3a is permanently affixed to the extreme proximal end of shell 1 along axis 8.
  • Manipulation loop 3b is permanently affixed to the distal end of shell 1 at a radial distance B from the outer diameter of the distal end of shell 1.
  • the attachments of manipulation loops 3a and 3b are reinforced by reinforcement sheets 9 and 10, respectively.
  • the height of shell 1 is approximately 139 mm
  • the diameters of the proximal and distal ends of shell 1 are approximately 83 mm and 153 mm, respectively
  • radial distances A and B are 30 mm and 20 mm, respectively.
  • the pelvic displacement prosthesis of the present invention is useful for patients undergoing surgical staging for advanced carcinoma of the cervix and other surgeries requiring radioprotection of the small bowel.
  • patients first have a laparotomy performed with para-aortic lymph nodes removed via a retroperitoneal approach. Any large or suspicious lymph nodes in the pelvis will also be removed if at all feasible.
  • the pelvic displacement prosthesis is placed, using manipulation loops 3a and 3b, into the pelvis and stitched, using absorbable sutures, onto the peritoneum and pelvis.
  • the prosthesis is then insufflated with normal saline to a sufficient volume to displace the small intestine above the pelvic brim.
  • the amount of fluid required is noted for each patient.
  • the tubing of the prosthesis is brought up through the abdominal wall and attached to the fascia in a location outside the radiation field and connected to an infusion port.
  • the prosthesis is tested prior to closure of the abdomen for ease of filling through the infusion port.
  • the patients may have a small bowel radiographic series performed prior to radiation to document displacement of the small bowel by the pelvic displacement prosthesis.
  • the pelvic displacement prosthesis may be insufflated with saline containing a small amount of radioopaque dye to aid in documenting displacement of the small bowel by the pelvic displacement prosthesis.
  • a small incision over the infusion port is performed using local anesthesia and intravenous sedation.
  • the infusion port is detached from the fascia and a small incision is made in the fascia just below this through which the pelvic displacement prosthesis is removed from the patient after desufflation of all the saline.
  • the wound in the fascia and skin is closed in a customary fashion.
  • the pelvic displacement prosthesis may be placed within the pelvis or removed therefrom laparoscopically, i.e. via a cannula or trocar.
  • This pelvic displacement prosthesis and method have at least the following benefits:
  • the most frequent cause of operation due to morbidity from radiation for cancer of the cervix involves small bowel injury.
  • the small intestines are constantly moving with peristaltic activity and, therefore, should receive less radiation than the stationary structures of the pelvis.
  • Volumes of the pelvis can range from 600-1000 cc.
  • a device which can be expanded to 1500 cc will adequately elevate the small intestine out of the radiation field.
  • the typical dose to the whole pelvis is sufficient to sterilize (i.e. kill) microscopic metastases of tumor to the pelvic lymph nodes.
  • a significant number of patients are at risk for lymph node metastases that will recur in the pelvis, often in the area of the pelvic lymph nodes.
  • the whole pelvic dose can be raised to the level of tolerance for the sigmoid colon - about 6000 rads - which should sterilize larger tumor volumes. This can have a significant impact on patient survival for those patients with unresectable or unresected lymph nodes, or those at high risk for having lymph node metastases. 3. Ease to patients.
  • This device can be implanted at the time of laparotomy for staging of cervical cancer.
  • the infusion port is brought out through the skin and secured with a suture to the anterior abdominal wall. This position assures that with insufflation of saline into the pelvic displacement prosthesis, the small intestines are elevated outside the pelvic cavity.
  • the infusion port is then be tunneled under the skin to a separate exit site to decrease the likelihood of infection along the tubing. 4. Economics.
  • the device can be removed in the office with local anesthesia, causing minimal inconvenience to patients. It is to be understood that the above-described embodiments are merely illustrative of the principles of the invention and that other arrangements may be devised by those skilled in the art without departing from the spirit and scope of the invention.

Abstract

A pelvic displacement prosthesis (100) for the radioprotection of the small bowel is provided. The prosthesis includes a shell (1) having a hollow frustum shape with one or more manipulation loops (3a, 3b) affixed thereto. A method for displacing the small bowel is also provided.

Description

PELVIC DISPLACEMENT PROSTHESIS FOR RADIOPROTECTION OF THE SMALL BOWEL
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to a pelvic displacement prosthesis for radioprotection of the small intestines (bowel), and a method therefor, in which the prosthesis is inserted into the pelvis to elevate the small bowel out of the pelvic cavity during radiation therapy.
2. Description of the Related Art
Radiation can be an effective therapy in early stage cervical carcinoma and is the treatment of choice in later stage disease. Typically, the patient receives between 4500 and 5040 centiGray (rads) of radiation via external beam teletherapy to the whole pelvis followed with brachytherapy implants which are placed directly on the tumor. The purpose of the whole pelvic radiation is to sterilize microscopic disease which may be in the lymph nodes, as well as to shrink the size of the primary tumor. The dosage to the whole pelvis is calculated to be within small bowel tolerance to radiation. The other primary structures in the pelvis, the bladder and colon, have a greater tolerance to radiation. If the radiation dosage to the pelvis could be raised without increasing the rate of radiation-related bowel complications, then the curative potential of the radiation would be enhanced.
Several methods have been described to keep the small bowel out of the pelvis during radiation. Historically, various slings made out of omentum or synthetic meshes have been attempted to keep the small bowel above the pelvic brim. Several devices have been tried which physically occupy the pelvic cavity such as breast implants, and "belly boards" to maintain the small bowel out of the pelvic cavity.
More recently, a prosthetic bladder has been utilized which is connected via tubing to a subcutaneous port so that the device can be insufflated or desufflated as needed during radiation therapy to elevate the small intestines out of the pelvic cavity. The device was used on 11 patients with none developing a complication in the follow-up period. The usual tolerable dose of radiation to the pelvis was increased in several patients secondary to the protection of the small intestine. This device was placed through a laparotomy and required a second small laparotomy to remove the instrument. In addition, an infusion port was placed beneath the skin of the abdomen to access the prosthetic bladder. This requires a separate incision to remove. While the inflated device did produce discomfort related to bowel and bladder pressure in some patients, inflation need occur only during the time the patient is receiving radiation, then the prosthetic bladder can be deflated for the remainder of the day.
Studies of these prior art devices revealed complications with small bowel tears due to adhesions and shearing forces at the time such devices were removed. The shape, conformity, and soft texture of the pelvic displacement prosthesis of present invention is ideal for placing into the pelvis and leaving in place for the duration of radiation. Constant, rather than intermittent, insufflation of the device causes less discomfort to the patient.
The prosthesis of the present invention integrates an expandable shell of sufficient shape and volume to elevate the small intestine out of the pelvic area during radiation when insufflated or filled. The prosthesis is connected via tubing to a valve or infusion port and can be filled with saline or other biologically compatible fluids. The tubing is located on the anterior or distal end of the device, so that, when the prosthesis is in place, the tubing will be located next to the anterior abdominal wall and away from the small intestine. The prosthesis of the present invention is designed so that, in its unfilled state, the prosthesis is of a size and shape that it can be placed and removed without a major surgical procedure. Because of the location of the tubing, the device may be removed by pulling on the tubing to bring the prosthesis up through the fascia such that any shearing forces are away from the small intestine thereby minimizing the risk of tearing the bowel. SUMMARY OF THE INVENTION
In order to solve the problems associated with the prior-art devices and methods described above, the invention provides for a novel pelvic displacement prosthesis for radioprotection of the small bowel. In a first embodiment, the pelvic displacement prosthesis includes a hollow frustum- shaped shell.
In another embodiment, the pelvic displacement prosthesis includes a hollow shell and one or more manipulation loops affixed to the exterior thereof.
In a further embodiment, the pelvic displacement prosthesis includes a hollow frustum-shaped shell and one or more manipulation loops affixed to the exterior thereof . The pelvic displacement prosthesis is inserted into the pelvis of a patient via an incision, laparotomy or laparoscopy. One or more manipulation loops are used to position the prosthesis within the pelvis. Fluid is supplied to or removed from the prosthesis through a tube connected to a valve or infusion port to insufflate or desufflate the shell. During treatment, radiation is applied to the desired area of the pelvis. Following treatment, the empty prosthesis is removed through an incision, laparotomy or laparoscopy using the tube or one or more of the manipulation loops.
BRIEF DESCRIPTION OF THE DRAWINGS Fig. 1 is an elevation view of a pelvic displacement prosthesis embodying aspects of the invention.
Fig. 2 is a plan view of a pelvic displacement prosthesis embodying aspects of the invention.
DETAILED DESCRIPTION OF THE DRAWINGS This embodiment of the pelvic displacement prosthesis is expandable with a capacity on the order of 750 - 1500 cc without approaching its restrictive compliance (i.e. without approaching a shell's bursting point). The shape of the prosthesis is such that upon insufflation it will conform to the pelvic anatomy, such as a circular or other shaped frustum. The prosthesis may be made with one or more manipulation loops which can be sewn to the peritoneum at approximately the pelvic brim and at the base of the exenteration (tumor) site. Some advantages of this feature of the prosthesis are the ease of insertion and removal of the prosthesis, and the ability to secure the prosthesis within the pelvis to prevent slippage of small intestine around the prosthesis which could become fixed in the radiation field. This embodiment of the prosthesis is made of material safe for long-term (2-3 months) intraperitoneal placement, such as silicone elastomer. This embodiment of the prosthesis is minimally radio-opaque so that the pelvis can be evaluated by standard radiologic procedures if a problem were to develop while on therapy. This embodiment of the prosthesis is fluidly connected to an infusion port via silicone tubing approximately 24 inches long so that it can be safely routed to an exit site out of the radiation field.
Fig. 1 is an elevation view, and Fig. 2 is a plan view, of a pelvic displacement prosthesis 100 embodying aspects of the present invention. The pelvic displacement prosthesis 100 includes shell 1, valve patch 2, manipulation loops 3a, 3b and tubing 6.
Shell 1 has a hollow frustum, or truncated-cone, shape having an axis 8. The radius of the proximal end of shell is smaller than that of its distal end. The proximal and distal ends of shell 1 have outwardly-projecting shallow conical surfaces. The extreme distal end of shell 1 is reinforced by reinforcement sheet 5.
Valve patch 2 is affixed via a fluid-tight connection to the distal end of shell 1. The axis of valve patch 2 is located at a radial distance A from the outer diameter of the distal end of shell 1. The connection between shell 1 and valve patch 2 is reinforced by reinforcement sheet 7. Tubing 6 is affixed via a fluid-tight connection to valve patch 2. Manipulation loop 3a is permanently affixed to the extreme proximal end of shell 1 along axis 8. Manipulation loop 3b is permanently affixed to the distal end of shell 1 at a radial distance B from the outer diameter of the distal end of shell 1. The attachments of manipulation loops 3a and 3b are reinforced by reinforcement sheets 9 and 10, respectively. In a preferred embodiment, the height of shell 1 is approximately 139 mm, the diameters of the proximal and distal ends of shell 1 are approximately 83 mm and 153 mm, respectively, and radial distances A and B are 30 mm and 20 mm, respectively.
The pelvic displacement prosthesis of the present invention is useful for patients undergoing surgical staging for advanced carcinoma of the cervix and other surgeries requiring radioprotection of the small bowel. Typically, patients first have a laparotomy performed with para-aortic lymph nodes removed via a retroperitoneal approach. Any large or suspicious lymph nodes in the pelvis will also be removed if at all feasible. At the completion of surgery, the pelvic displacement prosthesis is placed, using manipulation loops 3a and 3b, into the pelvis and stitched, using absorbable sutures, onto the peritoneum and pelvis. The prosthesis is then insufflated with normal saline to a sufficient volume to displace the small intestine above the pelvic brim. The amount of fluid required is noted for each patient. The tubing of the prosthesis is brought up through the abdominal wall and attached to the fascia in a location outside the radiation field and connected to an infusion port. The prosthesis is tested prior to closure of the abdomen for ease of filling through the infusion port.
Patients then undergo radiation therapy after recovery from their laparotomy in the usual manner. The patients may have a small bowel radiographic series performed prior to radiation to document displacement of the small bowel by the pelvic displacement prosthesis. In another method, the pelvic displacement prosthesis may be insufflated with saline containing a small amount of radioopaque dye to aid in documenting displacement of the small bowel by the pelvic displacement prosthesis.
At the completion of therapy, a small incision over the infusion port is performed using local anesthesia and intravenous sedation. The infusion port is detached from the fascia and a small incision is made in the fascia just below this through which the pelvic displacement prosthesis is removed from the patient after desufflation of all the saline. The wound in the fascia and skin is closed in a customary fashion.
In another method, the pelvic displacement prosthesis may be placed within the pelvis or removed therefrom laparoscopically, i.e. via a cannula or trocar.
This pelvic displacement prosthesis and method have at least the following benefits:
1. Decreased damage to the small bowel.
The most frequent cause of operation due to morbidity from radiation for cancer of the cervix involves small bowel injury. The small intestines are constantly moving with peristaltic activity and, therefore, should receive less radiation than the stationary structures of the pelvis. However, after surgeries for carcinoma of the cervix there is a higher likelihood of adhesion formation which tethers the small intestine and allows more radiation to be delivered to a finite portion, increasing the risk of reaching tissue tolerance. Volumes of the pelvis can range from 600-1000 cc. A device which can be expanded to 1500 cc will adequately elevate the small intestine out of the radiation field.
2. Increased radiation to the pelvis.
As previously mentioned, the typical dose to the whole pelvis is sufficient to sterilize (i.e. kill) microscopic metastases of tumor to the pelvic lymph nodes. After radiation therapy, a significant number of patients are at risk for lymph node metastases that will recur in the pelvis, often in the area of the pelvic lymph nodes. With the removal of the small intestines from the pelvis, the whole pelvic dose can be raised to the level of tolerance for the sigmoid colon - about 6000 rads - which should sterilize larger tumor volumes. This can have a significant impact on patient survival for those patients with unresectable or unresected lymph nodes, or those at high risk for having lymph node metastases. 3. Ease to patients.
This device can be implanted at the time of laparotomy for staging of cervical cancer. The infusion port is brought out through the skin and secured with a suture to the anterior abdominal wall. This position assures that with insufflation of saline into the pelvic displacement prosthesis, the small intestines are elevated outside the pelvic cavity. The infusion port is then be tunneled under the skin to a separate exit site to decrease the likelihood of infection along the tubing. 4. Economics.
At the completion of therapy, the device can be removed in the office with local anesthesia, causing minimal inconvenience to patients. It is to be understood that the above-described embodiments are merely illustrative of the principles of the invention and that other arrangements may be devised by those skilled in the art without departing from the spirit and scope of the invention.

Claims

What is claimed is:
1. A pelvic displacement prosthesis for radioprotection of the small bowel comprising a shell having a hollow frustum shape.
2. The pelvic displacement prosthesis of claim 1 further comprising a tube affixed to and in fluid communication with the interior of said shell.
3. The pelvic displacement prosthesis of claim 2 wherein said shell includes a proximal end and a distal end, wherein said distal end is larger than said proximal end, and said tube is affixed to said distal end.
4. The pelvic displacement prosthesis of claim 3 wherein said distal end has an outer edge, and said tube is affixed at a distance inward of said outer edge.
5. The pelvic displacement prosthesis of claim 1 wherein said shell includes proximal and distal ends, at least one of said ends having a outwardly projecting surface.
6. The pelvic displacement prosthesis of claim 1 wherein said shell has a substantially circular hollow frustum shape.
7. A pelvic displacement prosthesis for radioprotection of the small bowel comprising a hollow shell having proximal and distal ends, said shell having one or more manipulation loops affixed thereto.
8. The pelvic displacement prosthesis of claim 7 wherein a proximal manipulation loop is affixed to said proximal end.
9. The pelvic displacement prosthesis of claim 8 wherein said proximal end has a center of area, and said proximal manipulation loop is affixed approximately at said center of area.
10. The pelvic displacement prosthesis of claim 7 wherein a distal manipulation loop is affixed to said distal end.
11. The pelvic displacement prosthesis of claim 10 wherein said distal end has an outer edge, and said distal manipulation loop is affixed at a distance inward from said outer edge.
12. The pelvic displacement prosthesis of claim 7 further comprising a tube affixed to and in fluid communication with the interior of said shell.
13. The pelvic displacement prosthesis of claim 12 wherein said distal end has an outer edge, and said tube is affixed at a distance inward of said outer edge.
14. A pelvic displacement prosthesis for radioprotection of the small bowel comprising a shell having a hollow frustum shape and proximal and distal ends, said shell having one or more manipulation loops affixed thereto.
15. The pelvic displacement prosthesis of claim 14 further comprising a tube affixed to and in fluid communication with the interior of said shell.
16. The pelvic displacement prosthesis of claim 15 wherein said distal end is larger than said proximal end, and said tube is affixed to said distal end.
17. The pelvic displacement prosthesis of claim 16 wherein said distal end has an outer edge, and said tube is affixed at a distance inward from said outer edge.
18. The pelvic displacement prosthesis of claim 14 wherein at least one of said ends has a outwardly projecting surface.
19. The pelvic displacement prosthesis of claim 14 wherein said shell has a substantially circular hollow frustum shape.
20. The pelvic displacement prosthesis of claim 14 wherein a proximal manipulation loop is affixed to said proximal end.
21. The pelvic displacement prosthesis of claim 20 wherein said proximal end has a center of area, and said proximal manipulation loop is affixed approximately at said center of area.
22. The pelvic displacement prosthesis of claim 14 wherein a distal manipulation loop is affixed to said distal end.
23. The pelvic displacement prosthesis of claim 22 wherein said distal end has an outer edge, and said distal manipulation loop is affixed at a distance inward from said outer edge.
24. A radioprotection prosthesis for displacing the small bowel from the pelvis comprising: means for displacing the small bowel from the pelvis whereby said displacing means substantially conforms to an interior shape of the pelvis, and means for manipulating said displacing means and affixed thereto.
25. The radioprotection prosthesis of claim 24 further comprising means for the transmission of fluid, said fluid transmission means in fluid communication with said displacing means.
26. A method of displacing the small bowel from the pelvis comprising: introducing a hollow-shelled prosthesis into the pelvis, manipulating said prosthesis within the pelvis using one or more loops affixed to said prosthesis, and insufflating said prosthesis with a fluid.
27. The method of claim 26 wherein said insufflation includes substantially conforming said prosthesis to the shape of said pelvis.
28. The method of claim 26 wherein said fluid contains a radioopaque dye.
29. The method of claim 26 wherein at least one of said loops is affixed to the proximal end of said prosthesis.
30. The method of claim 26 further comprising securing said prosthesis within the pelvis.
31. The method of claim 26 where said prosthesis is laparoscopically introduced into the pelvis.
32. A method of displacing the small bowel from the pelvis comprising: introducing a hollow-shelled prosthesis having a f ustum shape into the pelvis, and insufflating said prosthesis with a fluid.
33. The method of claim 32 wherein said insufflation includes substantially conforming said prosthesis to the shape of said pelvis.
34. The method of claim 32 wherein said fluid contains a radioopaque dye.
35. The method of claim 32 wherein said prosthesis has a substantially circular hollow frustum shape.
36. The method of claim 32 further comprising securing said prosthesis within the pelvis.
37. The method of claim 32 where said prosthesis is laparoscopically introduced into the pelvis.
PCT/US1999/012220 1999-06-02 1999-06-02 Pelvic displacement prosthesis for radioprotection of the small bowel WO2000074573A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/US1999/012220 WO2000074573A1 (en) 1999-06-02 1999-06-02 Pelvic displacement prosthesis for radioprotection of the small bowel
AU43275/99A AU4327599A (en) 1999-06-02 1999-06-02 Pelvic displacement prosthesis for radioprotection of the small bowel

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/012220 WO2000074573A1 (en) 1999-06-02 1999-06-02 Pelvic displacement prosthesis for radioprotection of the small bowel

Publications (1)

Publication Number Publication Date
WO2000074573A1 true WO2000074573A1 (en) 2000-12-14

Family

ID=22272878

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1999/012220 WO2000074573A1 (en) 1999-06-02 1999-06-02 Pelvic displacement prosthesis for radioprotection of the small bowel

Country Status (2)

Country Link
AU (1) AU4327599A (en)
WO (1) WO2000074573A1 (en)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002102458A1 (en) * 2001-06-15 2002-12-27 Proxima Therapeutics, Inc. Apparatus for protecting tissue from radiotherapy
US7976554B2 (en) 2006-04-19 2011-07-12 Vibrynt, Inc. Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8001974B2 (en) 2006-04-19 2011-08-23 Vibrynt, Inc. Devices and methods for treatment of obesity
US8070768B2 (en) 2006-04-19 2011-12-06 Vibrynt, Inc. Devices and methods for treatment of obesity
US8187297B2 (en) 2006-04-19 2012-05-29 Vibsynt, Inc. Devices and methods for treatment of obesity
US8192455B2 (en) 2003-08-13 2012-06-05 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compressive device for percutaneous treatment of obesity
US8342183B2 (en) 2006-04-19 2013-01-01 Vibrynt, Inc. Devices and methods for treatment of obesity
US8382775B1 (en) 2012-01-08 2013-02-26 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume
US8398668B2 (en) 2006-04-19 2013-03-19 Vibrynt, Inc. Devices and methods for treatment of obesity
US8556925B2 (en) 2007-10-11 2013-10-15 Vibrynt, Inc. Devices and methods for treatment of obesity
US8585733B2 (en) 2006-04-19 2013-11-19 Vibrynt, Inc Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US9314362B2 (en) 2012-01-08 2016-04-19 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4643733A (en) * 1983-04-04 1987-02-17 Hilton Becker Permanent reconstruction implant and method of performing human tissue expansion
US4944749A (en) * 1985-01-23 1990-07-31 Hilton Becker Implant and inflating construction
US4950292A (en) * 1988-04-20 1990-08-21 Dow Corning Corporation Tissue expanders
US5337754A (en) * 1991-11-25 1994-08-16 Advanced Surgical, Inc. Inflatable isolation bag
US5735791A (en) * 1997-01-31 1998-04-07 Research Medical, Inc. Inflatable heart elevation apparatus and method

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4643733A (en) * 1983-04-04 1987-02-17 Hilton Becker Permanent reconstruction implant and method of performing human tissue expansion
US4944749A (en) * 1985-01-23 1990-07-31 Hilton Becker Implant and inflating construction
US4950292A (en) * 1988-04-20 1990-08-21 Dow Corning Corporation Tissue expanders
US5337754A (en) * 1991-11-25 1994-08-16 Advanced Surgical, Inc. Inflatable isolation bag
US5735791A (en) * 1997-01-31 1998-04-07 Research Medical, Inc. Inflatable heart elevation apparatus and method

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6673006B2 (en) 2001-06-15 2004-01-06 Proxima Therapeutics, Inc. Tissue positioning apparatus and method for protecting tissue from radiotherapy
US7494456B2 (en) 2001-06-15 2009-02-24 Cytyc Corporation Tissue positioning systems and methods for use with radiation therapy
WO2002102458A1 (en) * 2001-06-15 2002-12-27 Proxima Therapeutics, Inc. Apparatus for protecting tissue from radiotherapy
US8192455B2 (en) 2003-08-13 2012-06-05 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Compressive device for percutaneous treatment of obesity
US8342183B2 (en) 2006-04-19 2013-01-01 Vibrynt, Inc. Devices and methods for treatment of obesity
US8360069B2 (en) 2006-04-19 2013-01-29 Vibrynt, Inc. Devices and methods for treatment of obesity
US8187297B2 (en) 2006-04-19 2012-05-29 Vibsynt, Inc. Devices and methods for treatment of obesity
US8001974B2 (en) 2006-04-19 2011-08-23 Vibrynt, Inc. Devices and methods for treatment of obesity
US7976554B2 (en) 2006-04-19 2011-07-12 Vibrynt, Inc. Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8353925B2 (en) 2006-04-19 2013-01-15 Vibrynt, Inc. Devices and methods for treatment of obesity
US8356605B2 (en) 2006-04-19 2013-01-22 Vibrynt, Inc. Devices and methods for treatment of obesity
US8070768B2 (en) 2006-04-19 2011-12-06 Vibrynt, Inc. Devices and methods for treatment of obesity
US8585733B2 (en) 2006-04-19 2013-11-19 Vibrynt, Inc Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8398668B2 (en) 2006-04-19 2013-03-19 Vibrynt, Inc. Devices and methods for treatment of obesity
US8460321B2 (en) 2006-04-19 2013-06-11 Vibrynt, Inc. Devices, tools and methods for performing minimally invasive abdominal surgical procedures
US8556925B2 (en) 2007-10-11 2013-10-15 Vibrynt, Inc. Devices and methods for treatment of obesity
US8382775B1 (en) 2012-01-08 2013-02-26 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume
US9155528B2 (en) 2012-01-08 2015-10-13 Vibrynt, Inc. Methods, instruments and devices for extragastic reduction of stomach volume
US9314362B2 (en) 2012-01-08 2016-04-19 Vibrynt, Inc. Methods, instruments and devices for extragastric reduction of stomach volume

Also Published As

Publication number Publication date
AU4327599A (en) 2000-12-28

Similar Documents

Publication Publication Date Title
KR100470519B1 (en) Back-up retention member drainage catheter
US8900116B2 (en) Inflatable stomal implant
JP4824090B2 (en) Adjustable vaginal splint for pelvic floor support
JP3313112B2 (en) Surgical apparatus and method
ES2385323T3 (en) Remote adjustable gastric cerclage device
US6419701B1 (en) Adjustable implantable genitourinary device
US7947055B2 (en) Methods and devices for maintaining a space occupying device in a relatively fixed location within a stomach
Abu-Abeid et al. Results and complications of laparoscopic adjustable gastric banding: an early and intermediate experience
RU2372878C2 (en) Adjustable bandage assembly method
JP2003510104A (en) Apparatus and method for treating stress urinary incontinence, for example
US20080262406A1 (en) Securement device for shunt catheter and implantation method therefor
WO2000074573A1 (en) Pelvic displacement prosthesis for radioprotection of the small bowel
EP1607072B1 (en) An improved fluid adjustable band
US20170348089A1 (en) Adjustable breast implant with integral injection port
US20050027161A1 (en) Adjustable implantable genitourinary device
BRPI0408904B1 (en) Cystocele treatment implant and device for implant insertion
EP0837661A1 (en) Implantable support device
US20150164629A1 (en) Surgical methods and devices for treatment of prolapsed uterus
Soper et al. Absorbable synthetic mesh (910-polyglactin) intestinal sling to reduce radiation-induced small bowel injury in patients with pelvic malignancies
Crabtree et al. Laparoscopic implantation of swan neck presternal peritoneal dialysis catheters
US20140243588A1 (en) Implantable stoma ring
US20060030818A1 (en) System and method for securing a medical access device
CN116269920B (en) Empty pelvic cavity supporting bag body
RU2522385C2 (en) Method of suprapubic cystostomy in case of extraperitoneal breached integrity of urinary bladder walls
RU2160562C1 (en) Method for making preperitoneal hernioplasty in the cases of inguinal hernia

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW SD SL SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase